Evidence map›Paper›PMID 30563967›Full record

ArticleNature reviews. Nephrology2019

Author Correction: Estimated GFR: time for a critical appraisal.

Esteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, Fabiola Carrara, Alejandro Jiménez, Aiko P J de Vries, Armando Torres, Flavio Gaspari, Giuseppe Remuzzi

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. A Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Esteban PorriniHospital Universitario de Canarias, Tenerife, Spain. esteban.l.porrini@gmail.com.
Piero RuggenentiNephrology and Dialysis Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Sergio Luis-LimaHospital Universitario de Canarias, Tenerife, Spain.
Fabiola CarraraIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Ranica, Bergamo, Italy.
Alejandro JiménezHospital Universitario de Canarias, Tenerife, Spain.
Aiko P J de VriesLeiden University Medical Centre, Department of Medicine, Division of Nephrology, Leiden, Netherlands.
Armando TorresHospital Universitario de Canarias, Tenerife, Spain.
Flavio GaspariIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Ranica, Bergamo, Italy.
Giuseppe RemuzziNephrology and Dialysis Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the version of this article originally published online, the middle initials of Aiko P. J. de Vries, an author on the manuscript, were omitted. The omission has been corrected in the PDF and HTML versions of the article.

Identifiers

PMID30563967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.